Company intelligence / Profile preview

GeminiBio

West Sacramento, California, United States

Ownership: Private
Employees: ~80
Development stage: Other

Overview

GeminiBio is a leading manufacturer of cell culture sera, cGMP bioprocess liquids, media, and related tools, enabling biopharma, cell therapy, and gene therapy customers to optimize manufacturing workflows for research through commercial production. No therapeutics are in clinical development; GeminiBio provides enabling products for the development and production of biotherapeutics, cell therapies, and gene therapies.[1][2][3][5]

Industry: Chemicals & Materials

Partnerships

Bio-Techne (acquisition of selected fetal bovine serum product rights and inventory from Bio-Techne/R&D Systems)[5]

Beyond the preview

Go deeper on GeminiBio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeminiBio.

Explore the full profile